Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-16

Clinical Trial Update: Antimicrobial Activity of IV Clear™ Dressing - Prevention of Antimicrobial Regrowth [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the antimicrobial activity of the IV Clear dressing and its ability to prevent antimicrobial regrowth on skin flora.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IV Clear™ Dressing

Snippet

Sponsor: Covalon Technologies Inc. | Conditions: Skin Flora Infection | Phase 1 | Status: COMPLETED